• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW ORTHOPAEDICS LTD HEMI HEAD44MM; PROSTHESIS, HIP, HEMI-, FEMORAL, METAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW ORTHOPAEDICS LTD HEMI HEAD44MM; PROSTHESIS, HIP, HEMI-, FEMORAL, METAL Back to Search Results
Catalog Number 74122544
Medical Device Problem Code Biocompatibility (2886)
Health Effect - Clinical Codes Pain (1994); Metal Related Pathology (4530)
Date of Event 01/08/2025
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that, after undergoing a bhr-tha on (b)(6) 2012, the patient experienced hip pain that progressively got worse, with a painful clicking sensation.Laboratory tests showed elevated chromium and cobalt levels.Also, x-rays have shown some bone loss.Therefore, on 0(b)(6) 2025, a revision surgery was performed due to the mechanical complications and the metalosis with chronic inflammation from metal-on-metal.During this revision surgery, the system was converted to dual mobility hip system, so the acetabular cup hap size 44/50 and the bhr modular head 44mm were explanted.Osteolysis was found in the posterior aspect of the femur, as well as the anterior junction with the pubic rami.A synovectomy of the stained metallosis synovium all around the hip with sharp dissection and cautery for hemostasis.The patient was taken to the recovery room, having tolerated the procedure well.
 
Additional Manufacturer Narrative
Internal complaint reference: (b)(4).This complaint was opened by smith+nephew to document a patient complication reported that includes reference to the use of a smith+nephew product without evidence about a specific product problem.The reported complication relates to known inherent procedural risks that are appropriately documented in our risk files.Smith+nephew will continue to monitor trends in accordance with our post-market surveillance process and take necessary action as required if anticipated severity and/or occurrence rates are exceeded.Smith+nephew has no reason to suspect that the product failed to meet any specifications at the time of manufacture.Based on our review of all currently available information, we are unable to confirm a relationship between the reported event and the device or identify a definitive root cause.However, as the use of our product cannot be excluded as a potential cause or contributory factor to the reported issue, we are submitting this report in accordance with applicable regulations.If additional investigative findings or information becomes available that alters the conclusions of this report, a follow-up report will be submitted as required.
 
Additional Manufacturer Narrative
Internal complaint reference: case-(b)(4).Sections h6 (health effect - clinical code, type of investigation, investigation findings) h11: results of investigation: as of today, the implanted devices, all of which were used in treatment have not been returned for evaluation.A review of the historical complaints data for the alleged devices was performed using batch numbers, part numbers and the reported failure modes to evaluate patterns of repeated failures or defects.Similar complaints have been identified for the head and sleeve.No similar complaints have been identified for the cup.This failure will continue to be monitored via routine trending.In the absence of the actual devices, the production records were reviewed for the devices reportedly involved in this incident.All released devices involved met manufacturing specifications upon release for distribution.The review of the product ifu found adequate warnings and precautions in relation to the alleged failure modes.A risk management review was performed.The alleged failure modes and associated risks have been anticipated within the risk file and the anticipated risk level is still adequate.No further actions are required at this time.A review of historic escalation actions related to the products and similar complaint events was performed.Following the review, prior applicable escalation actions were identified and confirmed to reduce associated risks as far as possible.No further escalation actions are required.The available medical documents were reviewed.A clinical root cause could not be determined.The reported pain, elevated metal ions, and intraoperative findings of brown fluid are consistent with the reported metallosis.However, the clinical root cause of the metallosis cannot be definitively concluded.A definitive root cause cannot be determined.Specific factors known to contribute to the alleged fault are excessive physical activity levels, unreasonable stress on replacement system, excessive patient weight, trauma to the joint replacement, loosening of components may increase production of wear particles and accelerate damage to the bone.Should the devices or additional information be received, the complaint will be reopened.Based on this investigation, the need for corrective and preventative actions is not indicated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEMI HEAD44MM
Common Device Name
PROSTHESIS, HIP, HEMI-, FEMORAL, METAL
Manufacturer (Section D)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK  CV31 3HL
Manufacturer (Section G)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK   CV31 3HL
Manufacturer Contact
holly topping
1450 brooks rd.
memphis, TN 38116
5123913905
MDR Report Key23245538
Report Number3005975929-2025-00090
Device Sequence Number16058624
Product Code KWL
UDI-Device Identifier00885556070994
UDI-Public00885556070994
Combination Product (Y/N)N
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2012
Device Explanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Consumer,Health Professional,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 11/11/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/30/2013
Device Catalogue Number74122544
Device Lot Number08CW16088
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/15/2025
Supplement Date Received by Manufacturer11/04/2025
Initial Report FDA Received Date10/08/2025
Supplement Report FDA Received Date11/11/2025
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured03/31/2008
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
71309012/11KM16154/SYN POR PLUS HA SO STEM SZ 12.; 74122150/09BW21657/ACETABULAR CUP HAP SIZE 44/50.; 74222200/10ET42417/MODULAR SLEEVE {} PLUS 0MM 12/1.
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient Age64 YR
Patient SexFemale
Patient Weight63 KG
-
-